- Home
- GSK vs DEO Comparison
GSK vs DEO Comparison
Compare GSK & DEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- DEO
- Stock Information
- Founded
- GSK 1715
- DEO 1886
- Country
- GSK United Kingdom
- DEO United Kingdom
- Employees
- GSK 70200
- DEO N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- DEO Beverages (Production/Distribution)
- Sector
- GSK Health Care
- DEO Consumer Staples
- Exchange
- GSK Nasdaq
- DEO Nasdaq
- Market Cap
- GSK 68.6B
- DEO 66.3B
- IPO Year
- GSK N/A
- DEO N/A
- Fundamental
- Price
- GSK $33.60
- DEO $125.48
- Analyst Decision
- GSK Hold
- DEO Strong Buy
- Analyst Count
- GSK 5
- DEO 3
- Target Price
- GSK $45.50
- DEO N/A
- AVG Volume (30 Days)
- GSK 4.3M
- DEO 1.4M
- Earning Date
- GSK 02-05-2025
- DEO 01-28-2025
- Dividend Yield
- GSK 4.63%
- DEO 3.30%
- EPS Growth
- GSK N/A
- DEO N/A
- EPS
- GSK 0.81
- DEO 1.73
- Revenue
- GSK $41,966,224,352.00
- DEO $20,269,000,000.00
- Revenue This Year
- GSK $6.50
- DEO $3.41
- Revenue Next Year
- GSK $4.54
- DEO $4.29
- P/E Ratio
- GSK $20.12
- DEO $18.08
- Revenue Growth
- GSK 5.59
- DEO N/A
- 52 Week Low
- GSK $32.83
- DEO $117.72
- 52 Week High
- GSK $45.93
- DEO $154.71
- Technical
- Relative Strength Index (RSI)
- GSK 40.58
- DEO 51.40
- Support Level
- GSK $33.58
- DEO $125.29
- Resistance Level
- GSK $34.56
- DEO $132.34
- Average True Range (ATR)
- GSK 0.54
- DEO 1.69
- MACD
- GSK 0.01
- DEO 0.56
- Stochastic Oscillator
- GSK 17.28
- DEO 52.49
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About DEO Diageo plc
Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.